These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 33325808)
1. Hepatocyte-specific expression of human carboxylesterase 2 attenuates nonalcoholic steatohepatitis in mice. Xu Y; Pan X; Hu S; Zhu Y; Cassim Bawa F; Li Y; Yin L; Zhang Y Am J Physiol Gastrointest Liver Physiol; 2021 Jan; 320(2):G166-G174. PubMed ID: 33325808 [TBL] [Abstract][Full Text] [Related]
2. Carboxylesterase 2 prevents liver steatosis by modulating lipolysis, endoplasmic reticulum stress, and lipogenesis and is regulated by hepatocyte nuclear factor 4 alpha in mice. Li Y; Zalzala M; Jadhav K; Xu Y; Kasumov T; Yin L; Zhang Y Hepatology; 2016 Jun; 63(6):1860-74. PubMed ID: 26806650 [TBL] [Abstract][Full Text] [Related]
3. Hepatocyte miR-34a is a key regulator in the development and progression of non-alcoholic fatty liver disease. Xu Y; Zhu Y; Hu S; Pan X; Bawa FC; Wang HH; Wang DQ; Yin L; Zhang Y Mol Metab; 2021 Sep; 51():101244. PubMed ID: 33930596 [TBL] [Abstract][Full Text] [Related]
5. Lipocalin-2 Protects Against Diet-Induced Nonalcoholic Fatty Liver Disease by Targeting Hepatocytes. Xu Y; Zhu Y; Jadhav K; Li Y; Sun H; Yin L; Kasumov T; Chen X; Zhang Y Hepatol Commun; 2019 Jun; 3(6):763-775. PubMed ID: 31168511 [TBL] [Abstract][Full Text] [Related]
6. Hepatocyte Nuclear Factor 4α Prevents the Steatosis-to-NASH Progression by Regulating p53 and Bile Acid Signaling (in mice). Xu Y; Zhu Y; Hu S; Xu Y; Stroup D; Pan X; Bawa FC; Chen S; Gopoju R; Yin L; Zhang Y Hepatology; 2021 Jun; 73(6):2251-2265. PubMed ID: 33098092 [TBL] [Abstract][Full Text] [Related]
7. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice. Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105 [TBL] [Abstract][Full Text] [Related]
8. Fucoxanthin inhibits hepatic oxidative stress, inflammation, and fibrosis in diet-induced nonalcoholic steatohepatitis model mice. Takatani N; Kono Y; Beppu F; Okamatsu-Ogura Y; Yamano Y; Miyashita K; Hosokawa M Biochem Biophys Res Commun; 2020 Jul; 528(2):305-310. PubMed ID: 32475638 [TBL] [Abstract][Full Text] [Related]
9. Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice. Xu B; Jiang M; Chu Y; Wang W; Chen D; Li X; Zhang Z; Zhang D; Fan D; Nie Y; Shao F; Wu K; Liang J J Hepatol; 2018 Apr; 68(4):773-782. PubMed ID: 29273476 [TBL] [Abstract][Full Text] [Related]
10. Glucagon-like peptide-1 analogue prevents nonalcoholic steatohepatitis in non-obese mice. Yamamoto T; Nakade Y; Yamauchi T; Kobayashi Y; Ishii N; Ohashi T; Ito K; Sato K; Fukuzawa Y; Yoneda M World J Gastroenterol; 2016 Feb; 22(8):2512-23. PubMed ID: 26937139 [TBL] [Abstract][Full Text] [Related]
11. Hydrogen-rich water protects against liver injury in nonalcoholic steatohepatitis through HO-1 enhancement via IL-10 and Sirt 1 signaling. Li SW; Takahara T; Que W; Fujino M; Guo WZ; Hirano SI; Ye LP; Li XK Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G450-G463. PubMed ID: 33439102 [TBL] [Abstract][Full Text] [Related]
12. Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice. Luo L; Fang K; Dan X; Gu M Lipids Health Dis; 2019 Jan; 18(1):11. PubMed ID: 30621686 [TBL] [Abstract][Full Text] [Related]